Zhejiang Starry Pharmaceutical Co.,Ltd. 603520.SS Stock
Zhejiang Starry Pharmaceutical Co.,Ltd. Price Chart
Zhejiang Starry Pharmaceutical Co.,Ltd. 603520.SS Financial and Trading Overview
Contents
| Zhejiang Starry Pharmaceutical Co.,Ltd. stock price | 11.82 CNY |
| Previous Close | 16.98 CNY |
| Open | 16.99 CNY |
| Bid | 16.98 CNY x 0 |
| Ask | 16.99 CNY x 0 |
| Day's Range | 16.78 - 17.08 CNY |
| 52 Week Range | 15.6 - 32.98 CNY |
| Volume | 4.07M CNY |
| Avg. Volume | 4.54M CNY |
| Market Cap | 5.82B CNY |
| Beta (5Y Monthly) | 0.583787 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.17 CNY |
| Forward Dividend & Yield | 0.5 (3.06%) |
| Ex-Dividend Date | June 17, 2022 |
| 1y Target Est | 21.52 CNY |
603520.SS Valuation Measures
| Enterprise Value | 7.84B CNY |
| Trailing P/E | N/A |
| Forward P/E | 15.297297 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.6711385 |
| Price/Book (mrq) | 3.2754629 |
| Enterprise Value/Revenue | 3.595 |
| Enterprise Value/EBITDA | 33 |
Trading Information
Zhejiang Starry Pharmaceutical Co.,Ltd. Stock Price History
| Beta (5Y Monthly) | 0.583787 |
| 52-Week Change | -44.30% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 32.98 CNY |
| 52 Week Low | 15.6 CNY |
| 50-Day Moving Average | 17.25 CNY |
| 200-Day Moving Average | 19.06 CNY |
603520.SS Share Statistics
| Avg. Volume (3 month) | 4.54M CNY |
| Avg. Daily Volume (10-Days) | 3.68M CNY |
| Shares Outstanding | 342.91M |
| Float | 203.82M |
| Short Ratio | N/A |
| % Held by Insiders | 40.92% |
| % Held by Institutions | 14.60% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.5 |
| Trailing Annual Dividend Yield | 2.94% |
| 5 Year Average Dividend Yield | 131.00% |
| Payout Ratio | N/A |
| Last Split Factor | 1.4:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -6.72% |
| Operating Margin (ttm) | 3.60% |
| Gross Margin | 20.95% |
| EBITDA Margin | 10.89% |
Management Effectiveness
| Return on Assets (ttm) | 0.92% |
| Return on Equity (ttm) | -7.34% |
Income Statement
| Revenue (ttm) | 2.18B CNY |
| Revenue Per Share (ttm) | 6.39 CNY |
| Quarterly Revenue Growth (yoy) | 9.40% |
| Gross Profit (ttm) | 512.45M CNY |
| EBITDA | 237.49M CNY |
| Net Income Avi to Common (ttm) | -146517968 CNY |
| Diluted EPS (ttm) | -0.43 |
| Quarterly Earnings Growth (yoy) | -88.099% |
Balance Sheet
| Total Cash (mrq) | 778.73M CNY |
| Total Cash Per Share (mrq) | 2.27 CNY |
| Total Debt (mrq) | 3.02B CNY |
| Total Debt/Equity (mrq) | 169.33 CNY |
| Current Ratio (mrq) | 0.82 |
| Book Value Per Share (mrq) | 5.184 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -26784416 CNY |
| Levered Free Cash Flow (ttm) | -512546592 CNY |
Profile of Zhejiang Starry Pharmaceutical Co.,Ltd.
| Country | China |
| State | N/A |
| City | Xianju |
| Address | Xianju modern industrial cluster |
| ZIP | 317300 |
| Phone | 86 57 6877 18628 |
| Website | https://www.starrypharm.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 1842 |
Zhejiang Starry Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of X-CT non-ionic contrast agents and fluoroquinolones drugs and intermediates in China and internationally. Its contrast agent products include iohexol, iohexol hydrolysate, iohexol iodide, ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate; and fluoroquinolones products comprise levofloxacin, levofloxacin hydrochloride, levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufloxacin mesylate. The company was founded in 1997 and is based in Xianju, China.
Q&A For Zhejiang Starry Pharmaceutical Co.,Ltd. Stock
What is a current 603520.SS stock price?
Zhejiang Starry Pharmaceutical Co.,Ltd. 603520.SS stock price today per share is 11.82 CNY.
How to purchase Zhejiang Starry Pharmaceutical Co.,Ltd. stock?
You can buy 603520.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Zhejiang Starry Pharmaceutical Co.,Ltd.?
The stock symbol or ticker of Zhejiang Starry Pharmaceutical Co.,Ltd. is 603520.SS.
Which industry does the Zhejiang Starry Pharmaceutical Co.,Ltd. company belong to?
The Zhejiang Starry Pharmaceutical Co.,Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Zhejiang Starry Pharmaceutical Co.,Ltd. have in circulation?
The max supply of Zhejiang Starry Pharmaceutical Co.,Ltd. shares is 342.51M.
What is Zhejiang Starry Pharmaceutical Co.,Ltd. Price to Earnings Ratio (PE Ratio)?
Zhejiang Starry Pharmaceutical Co.,Ltd. PE Ratio is now.
What was Zhejiang Starry Pharmaceutical Co.,Ltd. earnings per share over the trailing 12 months (TTM)?
Zhejiang Starry Pharmaceutical Co.,Ltd. EPS is -0.17 CNY over the trailing 12 months.
Which sector does the Zhejiang Starry Pharmaceutical Co.,Ltd. company belong to?
The Zhejiang Starry Pharmaceutical Co.,Ltd. sector is Healthcare.
Stocks Related By Sector
- Shanghai Labway Clinical Laboratory Co., Ltd 301060.SZ Stock
- Jiangsu Bioperfectus Technologies Co., Ltd. 688399.SS Stock
- LanZhou Foci Pharmaceutical Co.,Ltd. 002644.SZ Stock
- Jiangxi Synergy Pharmaceutical Co., Ltd. 300636.SZ Stock
- Beijing Bohui Innovation Biotechnology Group Co., Ltd. 300318.SZ Stock